Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Craxì

Showing results (1-10 of 274) with videos related to

Pageof 28
Sort By:
Antiviral Therapy|December 25, 2009
Reducing treatment duration in patients infected with hepatitis C genotype 1: any need for further studies?Antonio Craxì
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 7, 2008
Introduction. Necroinflammation and the course of chronic hepatitisAntonio Craxì
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
Early virologic response with pegylated interferonsAntonio Craxì
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 13, 2020
Luigi Pagliaro, 1931-2020Antonio Craxì
Journal of Hepatology|November 14, 2009
PEG IFN alfa-2a vs. alfa-2b: and the winner is ...?Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Optimal therapy in hepatitis C virus genotypes 2 and 3 patientsSalvatore Petta, Antonio Craxì
Hepatology (Baltimore, Md.)|June 23, 2015
ReplySalvatore Petta, Antonio Craxì
Clinics in Liver Disease|April 16, 2005
Prevention of hepatocellular carcinomaAntonio Craxì, Calogero Cammà
Journal of Viral Hepatitis|August 7, 2009
Implication of normal liver enzymes in liver diseaseVincenza Calvaruso, Antonio Craxì
Journal of Hepatology|December 21, 2020
Reply to: "Hepatic benefits of HCV cure: Don't forget coagulation!"Vincenza Calvaruso, Antonio Craxì
Pageof 28

Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
Antiviral Therapy|December 25, 2009
Reducing treatment duration in patients infected with hepatitis C genotype 1: any need for further studies?Antonio Craxì
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 7, 2008
Introduction. Necroinflammation and the course of chronic hepatitisAntonio Craxì
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 14, 2005
Early virologic response with pegylated interferonsAntonio Craxì
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 13, 2020
Luigi Pagliaro, 1931-2020Antonio Craxì
Journal of Hepatology|November 14, 2009
PEG IFN alfa-2a vs. alfa-2b: and the winner is ...?Antonio Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Optimal therapy in hepatitis C virus genotypes 2 and 3 patientsSalvatore Petta, Antonio Craxì
Hepatology (Baltimore, Md.)|June 23, 2015
ReplySalvatore Petta, Antonio Craxì
Clinics in Liver Disease|April 16, 2005
Prevention of hepatocellular carcinomaAntonio Craxì, Calogero Cammà
Journal of Viral Hepatitis|August 7, 2009
Implication of normal liver enzymes in liver diseaseVincenza Calvaruso, Antonio Craxì
Journal of Hepatology|December 21, 2020
Reply to: "Hepatic benefits of HCV cure: Don't forget coagulation!"Vincenza Calvaruso, Antonio Craxì
Pageof 28